Vallon Pharmaceuticals Inc (VLON)


Stock Price Forecast

April 21, 2023


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Vallon Pharmaceuticals Inc chart...

About the Company

Vallon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company, headquartered in Philadelphia, PA. The Company is focused on the development of new medications to help patients with central nervous system (CNS) disorders. The Company’s lead investigational product candidate, ADAIR, is a novel abuse deterrent formulation of amphetamine immediate release being developed for the treatment of ADHD and narcolepsy.

Exchange

NASDAQ

Website

www.vallon-pharma.com

$0M

Total Revenue

2

Employees

$162M

Market Capitalization

-16.93

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $VLON News

Cancer Focused Micro-Cap Xilio Therapeutics Stock Doubles In One Session - Here's Why

on MSN ago, source:

Xilio Therapeutics Inc (NASDAQ:XLO) shares are surging as the company announced an exclusive license agreement with Gilead ...

Analyst Issues Sell Rating for Vertex Pharmaceuticals Amid Intensifying Drug Market Competition

6d ago, source:

Whitney Ijem, an analyst from Canaccord Genuity, maintained the Sell rating on Vertex Pharmaceuticals (VRTX – Research Report). The ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...